CTNI-02. PRECLINICAL DATA AND INITIAL CLINICAL EXPERIENCE IN THE PHASE 1/2A DOSE ESCALATION TRIAL OF RHENIUM-186 NANOLIPOSOME (186RNL) IN LEPTOMENINGEAL METASTASES [LM]: THE RESPECT-LM TRIAL
Authors: Andrew Brenner, Michael Youssef, Norman LaFrance, Marc Hedrick, Ande Bao, William Phillips, Toral Patel, Jeffrey Weinberg, John Floyd